(Q34047473)

30 July 2017

1 reference

title

Version 2000: the new beta-lactamases of Gram-negative bacteria at the dawn of the new millennium (English)

1 reference

30 July 2017

Gram-negative bacteria

0 references

author name string

K S Thomson

series ordinal

1

1 reference

PubMed ID

11008112

30 July 2017

E Smith Moland

series ordinal

2

1 reference

30 July 2017

1 August 2000

1 reference

30 July 2017

Microbes and Infection

1 reference

30 July 2017

2

1 reference

30 July 2017

10

1 reference

30 July 2017

1225-1235

1 reference

Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

The structure of β-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

A functional classification scheme for beta-lactamases and its correlation with molecular structure

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Methodology for the study of beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Characterization of beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Beta-lactamase-mediated resistance and opportunities for its control.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Serine beta-lactamases and penicillin-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

TEM- and SHV-derived extended-spectrum beta-lactamases: relationship between selection, structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Characterization of a new TEM-derived beta-lactamase produced in a Serratia marcescens strain

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

A novel extended-spectrum TEM-type beta-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

More extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

TEM-24 produced by four different species of Enterobacteriaceae, including Providencia rettgeri, in a single patient

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Updated sequence information for TEM beta-lactamase genes.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Extended-spectrum beta-lactamases in Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Evolution and spread of SHV extended-spectrum beta-lactamases in gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Epidemiology of extended spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Epidemiology of extended-spectrum beta-lactamases.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

A simple and reliable method to screen isolates of Escherichia coli and Klebsiella pneumoniae for the production of TEM- and SHV-derived extended-spectrum beta-lactamases.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Mechanism and stability of hyperproduction of the extended-spectrum beta-lactamase SHV-5 in Klebsiella pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

CTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurium in Latvia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Extended spectrum beta-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

In vitro and in vivo transferrable beta-lactam resistance due to a new plasmid-mediated oxyiminocephalosporinase from a clinical isolate of Proteus mirabilis.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Concurrent outbreaks of extended-spectrum beta-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

A novel plasmid-medlated extended-spectrum β-lactamase not derived from TEM- or SHV-type enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Transferable production of PER-1 beta-lactamase in Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Cloning of a Chryseobacterium (Flavobacterium) meningosepticum chromosomal gene (blaA(CME)) encoding an extended-spectrum class A beta-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Laboratory mutants of OXA-10 beta-lactamase giving ceftazidime resistance in Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Novel OXA-10-derived extended-spectrum beta-lactamases selected in vivo or in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Frequency of inhibitor-resistant TEM beta-lactamases in Escherichia coli isolates from urinary tract infections in France

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

beta-Lactam resistance in gram-negative bacteria: global trends and clinical impact

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

beta-Lactamases in laboratory and clinical resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Origin and impact of plasmid-mediated extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Plasmid-encoded AmpC beta-lactamases: how far have we gone 10 years after the discovery?

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Carbapenem-hydrolyzing beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Acquired carbapenemases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-beta-lactamase IMP-1 produced by Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Worldwide proliferation of carbapenem-resistant gram-negative bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Resistance to and hydrolysis of imipenem in nosocomial strains of Flavobacterium meningosepticum.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Hydrolysis of imipenem, meropenem, ceftazidime, and cefepime by multiresistant nosocomial strains of Sphingobacterium multivorum

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Carbapenem-hydrolysing IMP-1 beta-lactamase in Klebsiella pneumoniae from Singapore.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Carbapenem-hydrolysing beta-lactamase from clinical isolates of Pseudomonas aeruginosa in Portugal.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Carbapenem resistance in a clinical isolate of Citrobacter freundii

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Biochemical characteristics of a carbapenemase from an Acinetobacter baumannii isolate collected in Buenos Aires, Argentina.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

The production of a novel carbapenem-hydrolysing beta-lactamase in Aeromonas veronii biovar sobria, and its association with imipenem resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901276-4

7 January 2021

10.1016/S1286-4579(00)01276-4

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11008112